![PDF) The efficacy of a medical food (Souvenaid ®) in Alzheimer's disease: Results from the first trial and design of future trials PDF) The efficacy of a medical food (Souvenaid ®) in Alzheimer's disease: Results from the first trial and design of future trials](https://i1.rgstatic.net/publication/245820372_The_efficacy_of_a_medical_food_Souvenaid_R_in_Alzheimer's_disease_Results_from_the_first_trial_and_design_of_future_trials/links/59e89196458515c363133f8f/largepreview.png)
PDF) The efficacy of a medical food (Souvenaid ®) in Alzheimer's disease: Results from the first trial and design of future trials
![Assessment of a Potential Synergistic Effect of Souvenaid ® in Mild Alzheimer's Disease Patients on Treatment with Acetylcholinesterase Inhibitors: An Observational, Non-Interventional Study - IOS Press Assessment of a Potential Synergistic Effect of Souvenaid ® in Mild Alzheimer's Disease Patients on Treatment with Acetylcholinesterase Inhibitors: An Observational, Non-Interventional Study - IOS Press](https://content.iospress.com/media/jad/2021/80-4/jad-80-4-jad201357/jad-80-jad201357-g002.jpg?width=755)
Assessment of a Potential Synergistic Effect of Souvenaid ® in Mild Alzheimer's Disease Patients on Treatment with Acetylcholinesterase Inhibitors: An Observational, Non-Interventional Study - IOS Press
![Souvenaid results offer hope for those with early Alzheimer's disease, including Mild Cognitive Impairment | Alzheimer's Disease International (ADI) Souvenaid results offer hope for those with early Alzheimer's disease, including Mild Cognitive Impairment | Alzheimer's Disease International (ADI)](https://www.alzint.org/u/General-Research-1.png)
Souvenaid results offer hope for those with early Alzheimer's disease, including Mild Cognitive Impairment | Alzheimer's Disease International (ADI)
![PDF) The S-Connect study: Results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer's disease PDF) The S-Connect study: Results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer's disease](https://i1.rgstatic.net/publication/258954026_The_S-Connect_study_Results_from_a_randomized_controlled_trial_of_Souvenaid_in_mild-to-moderate_Alzheimer's_disease/links/0a85e539f5c3c67dcf000000/largepreview.png)
PDF) The S-Connect study: Results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer's disease
![Frontiers | N-of-1 Clinical Trials in Nutritional Interventions Directed at Improving Cognitive Function | Nutrition Frontiers | N-of-1 Clinical Trials in Nutritional Interventions Directed at Improving Cognitive Function | Nutrition](https://www.frontiersin.org/files/Articles/439023/fnut-06-00110-HTML/image_m/fnut-06-00110-g001.jpg)
Frontiers | N-of-1 Clinical Trials in Nutritional Interventions Directed at Improving Cognitive Function | Nutrition
![PDF) The Effect of Souvenaid on Functional Brain Network Organisation in Patients with Mild Alzheimer's Disease: A Randomised Controlled Study PDF) The Effect of Souvenaid on Functional Brain Network Organisation in Patients with Mild Alzheimer's Disease: A Randomised Controlled Study](https://i1.rgstatic.net/publication/259961386_The_Effect_of_Souvenaid_on_Functional_Brain_Network_Organisation_in_Patients_with_Mild_Alzheimer's_Disease_A_Randomised_Controlled_Study/links/0a85e52eac1498d8ba000000/largepreview.png)
PDF) The Effect of Souvenaid on Functional Brain Network Organisation in Patients with Mild Alzheimer's Disease: A Randomised Controlled Study
![P1‐278: The efficacy of a medical food (Souvenaid®) in Alzheimer's disease: Results from the first trial and design of future trials - Scheltens - 2009 - Alzheimer's & Dementia - Wiley Online Library P1‐278: The efficacy of a medical food (Souvenaid®) in Alzheimer's disease: Results from the first trial and design of future trials - Scheltens - 2009 - Alzheimer's & Dementia - Wiley Online Library](https://alz-journals.onlinelibrary.wiley.com/cms/asset/d47a698c-0efe-492e-a65c-c0f7d92c673f/alz.v5.4s_part_9.cover.jpg)
P1‐278: The efficacy of a medical food (Souvenaid®) in Alzheimer's disease: Results from the first trial and design of future trials - Scheltens - 2009 - Alzheimer's & Dementia - Wiley Online Library
Chemist Discount Centre - Alzheimer's disease affects almost 500,000 Australians. A new study has found significant benefits in slowing the condition with long term use of Souvenaid®.* The three-year results from
![PDF] Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial. | Semantic Scholar PDF] Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f5f4e5c2f171378d95c3180ae8c2898ab08ac3bc/5-Figure1-1.png)
PDF] Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial. | Semantic Scholar
![24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial - The Lancet Neurology 24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial - The Lancet Neurology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2119347686/2092556969/gr1.gif)